Edited by Peter Hillerberg1 min readStories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
TSLA is the headline story today. The company beat Q3 delivery expectations, and analyst Gene Munster has since called it the start of something bigger, predicting Tesla will outrun traditional rivals. GM and Ford face fresh pressure on that narrative. The delivery beat arrives as options flow in chips and autos stays heavy, with MU drawing the largest two-sided bets in the semiconductor space.
Semiconductor names are attracting heavy options activity on both sides. and are in the mix alongside Micron. draws bearish bets despite a 223% year-to-date gain. Options traders appear unconvinced the rally holds. In biotech, Russia-linked plague reports sent money toward and .
UBS downgraded OI (O-I Glass) to Neutral with a $6 target. That continues a pattern of analysts cutting targets in materials and chemicals. Citigroup trimmed targets on several medical device makers. JNJ was the lone upgrade, lifted to $303. Consumer names including PEP face their biggest test of the week when PepsiCo reports Thursday before the open. Volume data will be the key figure to watch.
Spanish inflation hit 5.0% in September on the HICP measure, a third straight monthly rise. France matched the trend at 3.4%. Two of the eurozone's four largest economies are now printing accelerating inflation at the same time. Against that backdrop, new diesel car registrations across tracked European markets fell to 1,471 units in September, the lowest September on record since 2016. The electric transition is compressing the diesel base even as broader price pressures build.
Remaining buyback authorisations reached $58.2bn in Q2 2026, the largest Q2 figure since records began in 2013. Actual shares repurchased fell 34% year-on-year, suggesting companies are reserving capacity rather than deploying it.
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
